Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.6676
-0.0022 (-0.33%)
At close: Apr 2, 2025, 4:00 PM
0.6688
+0.0012 (0.18%)
After-hours: Apr 2, 2025, 7:50 PM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $2.94 million as of April 2, 2025. Its market cap has decreased by -11.05% in one year.
Market Cap
2.94M
Enterprise Value
-6.73M
1-Year Change
-11.05%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since March 30, 2007, Palisade Bio's market cap has decreased from $82.40M to $2.94M, a decrease of -96.44%. That is a compound annual growth rate of -16.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 2.90M | 31.82% |
| Dec 31, 2024 | 2.20M | -59.26% |
| Dec 29, 2023 | 5.40M | -32.50% |
| Dec 30, 2022 | 8.00M | -54.55% |
| Dec 31, 2021 | 17.60M | 15.79% |
| Dec 31, 2020 | 15.20M | 300.00% |
| Dec 31, 2019 | 3.80M | -33.33% |
| Dec 31, 2018 | 5.70M | -78.08% |
| Dec 29, 2017 | 26.00M | -16.13% |
| Dec 30, 2016 | 31.00M | -67.02% |
| Dec 31, 2015 | 94.00M | -60.62% |
| Dec 31, 2014 | 238.70M | 6.23% |
| Dec 31, 2013 | 224.70M | 203.65% |
| Dec 31, 2012 | 74.00M | 55.14% |
| Dec 30, 2011 | 47.70M | -51.92% |
| Dec 31, 2010 | 99.20M | 57.96% |
| Dec 31, 2009 | 62.80M | 20.54% |
| Dec 31, 2008 | 52.10M | -54.10% |
| Dec 31, 2007 | 113.50M | 37.74% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.75B |
| UnitedHealth Group | 478.58B |
| Johnson & Johnson | 374.39B |
| AbbVie | 362.98B |
| Novo Nordisk | 301.38B |
| Abbott Laboratories | 228.81B |
| AstraZeneca | 225.76B |
| Merck & Co. | 218.75B |